Bioventus Inc. (BVS) Free Cash Flow
Bioventus Inc. (BVS) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2021-12-31 | $2.10M |
| 2022-12-31 | -$15.02M |
| 2023-12-31 | $7.98M |
| 2024-12-31 | $37.79M |
| 2025-12-31 | $72.11M |
How BVS compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| RIGL | Rigel Pharmaceuticals Inc. | $75.66M |
| USPH | U.S. Physical Therapy Inc. | $60.99M |
| PAHC | Phibro Animal Health Corporation | $41.83M |
| INNV | InnovAge Holding Corp. | $26.60M |
| VCEL | Vericel Corporation | $24.75M |
These are five companies in the same sector as BVS with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Bioventus Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("BVS", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | BVS | $13.78 | -1.36% | 0.03M |
| 3 | ||||
| 4 | ||||
| 5 |